Hilde Haukeland
- PhD student; MD
- +47 411 03 493
Research interests
I am a rheumatologist doing clinical work, but also engaged in research. I am interested in the rheumatic connective diseases, and involved in research on Systemic Lupus Erythematosus epidemiology as my PhD project. I have also been involved in research on Rheumatoid Arthritis and ANCA associated vasculitis.
PROJECT: NorSLE
Publications 2024
Declining Incidence of Systemic Lupus Erythematosus in Norway 1999-2017: Data From a Population Cohort Identified by International Classification of Diseases, 10th Revision Code and Verified by Classification
Arthritis Rheumatol, 76 (5), 715-725
DOI 10.1002/art.42775, PubMed 38108106
Sensitivity of classification criteria from time of diagnosis in an incident systemic lupus erythematosus cohort: a population-based study from Norway
RMD Open, 10 (3)
DOI 10.1136/rmdopen-2024-004395, PubMed 39160088
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
Lancet Rheumatol, 6 (5), e268-e278
DOI 10.1016/S2665-9913(24)00021-3, PubMed 38583450
The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population
RMD Open, 10 (2)
DOI 10.1136/rmdopen-2023-004039, PubMed 38580345
Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022
Rheumatology (Oxford), 63 (8), 2109-2117
DOI 10.1093/rheumatology/kead519, PubMed 37769251
Reply
Arthritis Rheumatol (in press)
DOI 10.1002/art.43031, PubMed 39415494
Publications 2023
Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis
Rheumatology (Oxford), 62 (9), 3213-3218
DOI 10.1093/rheumatology/kead152, PubMed 37004177
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
Ann Rheum Dis, 82 (11), 1394-1403
DOI 10.1136/ard-2023-224476, PubMed 37607809
Publications 2022
Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA
Rheumatology (Oxford), 61 (8), 3461-3470
DOI 10.1093/rheumatology/keab912, PubMed 34888651
Publications 2021
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial
JAMA, 325 (17), 1755-1764
DOI 10.1001/jama.2021.4542, PubMed 33944875
Long-Term Outcome in Systemic Lupus Erythematosus; Knowledge from Population-Based Cohorts
J Clin Med, 10 (19)
DOI 10.3390/jcm10194306, PubMed 34640322
Publications 2019
Development of CT-based methods for longitudinal analyses of paranasal sinus osteitis in granulomatosis with polyangiitis
BMC Med Imaging, 19 (1), 13
DOI 10.1186/s12880-019-0315-7, PubMed 30717680
Publications 2016
Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach
RMD Open, 2 (2), e000325
DOI 10.1136/rmdopen-2016-000325, PubMed 28074154
Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial
BMJ, 354, i4205
DOI 10.1136/bmj.i4205, PubMed 27530741
Publications 2015
First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach
Ann Rheum Dis, 75 (8), 1444-51
DOI 10.1136/annrheumdis-2015-207572, PubMed 26085490